132 related articles for article (PubMed ID: 1484754)
1. Delayed compliance increase in infants with respiratory distress syndrome following synthetic surfactant.
Armsby DH; Bellon G; Carlisle K; Rector D; Baldwin R; Long W; Stevenson DK; Ariagno RL
Pediatr Pulmonol; 1992 Dec; 14(4):206-13. PubMed ID: 1484754
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations.
Choukroun ML; Llanas B; Apere H; Fayon M; Galperine RI; Guenard H; Demarquez JL
Pediatr Pulmonol; 1994 Nov; 18(5):273-8. PubMed ID: 7898964
[TBL] [Abstract][Full Text] [Related]
3. Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.
Stenson BJ; Glover RM; Parry GJ; Wilkie RA; Laing IA; Tarnow-Mordi WO
Arch Dis Child Fetal Neonatal Ed; 1994 Jan; 70(1):F19-24. PubMed ID: 8117122
[TBL] [Abstract][Full Text] [Related]
4. Exosurf rescue surfactant improves high ventilation-perfusion mismatch in respiratory distress syndrome.
Billman D; Nicks J; Schumacher R
Pediatr Pulmonol; 1994 Nov; 18(5):279-83. PubMed ID: 7898965
[TBL] [Abstract][Full Text] [Related]
5. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant.
Bhutani VK; Abbasi S; Long WA; Gerdes JS
J Pediatr; 1992 Feb; 120(2 Pt 2):S18-24. PubMed ID: 1735846
[TBL] [Abstract][Full Text] [Related]
7. Lung mechanics and gas exchange in ventilated preterm infants during treatment of hyaline membrane disease with multiple doses of artificial surfactant (Exosurf).
Pfenninger J; Aebi C; Bachmann D; Wagner BP
Pediatr Pulmonol; 1992 Sep; 14(1):10-5. PubMed ID: 1437337
[TBL] [Abstract][Full Text] [Related]
8. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
Dechant KL; Faulds D
Drugs; 1991 Nov; 42(5):877-94. PubMed ID: 1723378
[TBL] [Abstract][Full Text] [Related]
9. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
[TBL] [Abstract][Full Text] [Related]
10. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
[TBL] [Abstract][Full Text] [Related]
11. Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant.
Abbasi S; Bhutani VK; Gerdes JS
J Pediatr; 1993 Mar; 122(3):446-52. PubMed ID: 8441104
[TBL] [Abstract][Full Text] [Related]
12. [Use of Exosurf Neonatal, a synthetic surfactant, in the treatment of respiratory distress syndrome in the newborn].
Mikhel'sonVA ; Grebennikov VA; Belaĭ VA; Everstova TN
Anesteziol Reanimatol; 1995; (1):4-7. PubMed ID: 7605034
[TBL] [Abstract][Full Text] [Related]
13. Postnatal changes in pulmonary mechanics and energetics of infants with respiratory distress syndrome following surfactant treatment.
Bhutani VK; Bowen FW; Sivieri EM
Biol Neonate; 2005; 87(4):323-31. PubMed ID: 15985755
[TBL] [Abstract][Full Text] [Related]
14. Prediction of the acute response to surfactant therapy by pulmonary function testing.
Wallenbrock MA; Sekar KC; Toubas PL
Pediatr Pulmonol; 1992 May; 13(1):11-5. PubMed ID: 1589306
[TBL] [Abstract][Full Text] [Related]
15. Surfactant replacement therapy improves ventilation inhomogeneity in infants with respiratory distress syndrome.
Sandberg KL; Lindstrom DP; Sjöqvist BA; Parker RA; Cotton RB
Pediatr Pulmonol; 1997 Nov; 24(5):337-43. PubMed ID: 9407567
[TBL] [Abstract][Full Text] [Related]
16. [Outcome of blood gas parameters during the first 24 years after Exosurf administration].
Lenoir S; Grandjean H; Claris O; Hascoët JM
Arch Pediatr; 1996 Apr; 3(4):324-8. PubMed ID: 8762952
[TBL] [Abstract][Full Text] [Related]
17. Early versus delayed neonatal administration of a synthetic surfactant--the judgment of OSIRIS. The OSIRIS Collaborative Group (open study of infants at high risk of or with respiratory insufficiency--the role of surfactant.
Lancet; 1992 Dec; 340(8832):1363-9. PubMed ID: 1360087
[TBL] [Abstract][Full Text] [Related]
18. Energy expenditure during synthetic surfactant replacement therapy for neonatal respiratory distress syndrome.
Hazan J; Chessex P; Piedboeuf B; Bourgeois M; Bard H; Long W
J Pediatr; 1992 Feb; 120(2 Pt 2):S29-33. PubMed ID: 1735848
[TBL] [Abstract][Full Text] [Related]
19. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R
J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
[TBL] [Abstract][Full Text] [Related]
20. Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).
Häfner D; Beume R; Kilian U; Krasznai G; Lachmann B
Br J Pharmacol; 1995 Jun; 115(3):451-8. PubMed ID: 7582456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]